Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DIGIT (divergent to GSC, induced by TGF-beta family signaling), also known as GSC divergent transcript or GSC-DT, is a long noncoding RNA (lncRNA) induced by TGF-beta signaling during endodermal differentiation[1][5]. DIGIT is divergently transcribed from the GSC (Goosecoid homeobox) gene locus and is coordinately induced with GSC in embryonic stem cells undergoing differentiation[1]. It regulates endoderm differentiation by controlling GSC expression in trans, and DIGIT deficiency impairs this process; forced GSC expression can rescue the differentiation defect in DIGIT-deficient cells[1]. As a noncoding RNA, DIGIT does not encode a protein and is not considered a therapeutic target such as a receptor or enzyme. It functions at the regulatory level during development, primarily by modulating the expression of key lineage determinants in response to TGF-beta/SMAD3 signaling[1][5][3]. There is no evidence of direct association with drugs, clinical biomarkers, or established disease roles, though it may influence disease-relevant pathways such as TGF-beta signaling.
Not applicable (no known direct drug targeting)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DIGIT (divergent to GSC, induced by TGF-beta family signaling) (DIGIT).